Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Fluzone High-Dose vs Fluzone in Elderly
NCT00976027Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Sep 2009
- Primary completion
- May 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Sep 2009; status: terminated.
02
Drugs
trivalent inactivated influenza vaccine high-dose
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00976027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976027.